These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 6354522)

  • 1. Dopaminergic blockade of the renin-angiotensin-aldosterone system: effect of high and low sodium intakes.
    Gordon MB; Moore TJ; Dluhy RG; Williams GH
    Clin Endocrinol (Oxf); 1983 Oct; 19(4):415-25. PubMed ID: 6354522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. Dopaminergic control of aldosterone.
    Carey RM; Thorner MO; Ortt EM
    J Clin Invest; 1979 Apr; 63(4):727-35. PubMed ID: 438333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopaminergic modulation of aldosterone secretion in the rat.
    Aguilera G; Catt KJ
    Endocrinology; 1984 Jan; 114(1):176-81. PubMed ID: 6317344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopaminergic modulation of aldosterone responsiveness to angiotensin II with changes in sodium intake.
    Gordon MB; Moore TJ; Dluhy RG; Williams GH
    J Clin Endocrinol Metab; 1983 Feb; 56(2):340-5. PubMed ID: 6822640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic modulation of aldosterone secretion: effect of sodium balance and postural changes.
    García-Robles R; Ruilope L; Mancheño E; Hurtado A; Alcázar JM; Varela C; de la Calle H; Rodicio JL; Sancho J
    Rev Esp Fisiol; 1984 Mar; 40(1):63-8. PubMed ID: 6087430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of sodium homeostasis on dopaminergic modulation of aldosterone, renin, and prolactin secretion in man.
    Sowers JR; Glub MS; Eggena PH; Catania RA
    J Clin Endocrinol Metab; 1982 Jan; 54(1):121-6. PubMed ID: 7033264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. beta-Endorphin stimulates plasma renin and aldosterone release in normal human subjects.
    Rabinowe SL; Taylor T; Dluhy RG; Williams GH
    J Clin Endocrinol Metab; 1985 Mar; 60(3):485-9. PubMed ID: 3156142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type II diabetes mellitus.
    Price DA; De'Oliveira JM; Fisher ND; Williams GH; Hollenberg NK
    Am J Hypertens; 1999 Apr; 12(4 Pt 1):348-55. PubMed ID: 10232494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of metoclopramide, a dopamine antagonist, on secretion of aldosterone and renin release in patients with primary aldosteronism.
    Mizuno K; Yamazaki M; Ikeda K; Yaginuma K; Hashimoto S; Fukuchi S
    Jpn Heart J; 1983 Nov; 24(6):917-24. PubMed ID: 6323781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A specific role for saline or the sodium ion in the regulation of renin and aldosterone secretion.
    Tuck ML; Dluhy RG; Williams GH
    J Clin Invest; 1974 Apr; 53(4):988-95. PubMed ID: 4360859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine modulates sodium-dependent aldosterone responses to angiotensin II in humans.
    Drake CR; Carey RM
    Hypertension; 1984; 6(2 Pt 2):I119-23. PubMed ID: 6373591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute dopaminergic inhibition of aldosterone secretion is independent of angiotensin II and adrenocorticotropin.
    Carey RM
    J Clin Endocrinol Metab; 1982 Feb; 54(2):463-9. PubMed ID: 6274907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central and peripheral effects of dopamine on the renin-angiotensin-aldosterone system in conscious rats.
    Kondo K; Suzuki H; Handa M; Nagahama S; Yasui T; Fujimaki M; Ogihara T; Saruta T
    Jpn Circ J; 1981 Sep; 45(9):1121-5. PubMed ID: 7029031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopaminergic suppression of angiotensin II-induced aldosterone secretion in man: differential responses during sodium loading and depletion.
    Drake CR; Ragsdale NV; Kaiser DL; Carey RM
    Metabolism; 1984 Aug; 33(8):696-702. PubMed ID: 6379373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of prolactin and the renin-angiotensin system in mediating dopaminergic control of aldosterone secretion in the rat.
    Sowers JR; Golub M; Tuck M; Sowers DK
    Clin Exp Hypertens (1978); 1981; 3(1):1-14. PubMed ID: 7472089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenal responses to pharmacological interruption of the renin-angiotensin system in sodium-restricted normal man.
    Williams GH; Hollenberg NK; Brown C; Mersey JH
    J Clin Endocrinol Metab; 1978 Oct; 47(4):725-31. PubMed ID: 400731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the renin-angiotensin system in the regulation of aldosterone biosynthesis and arterial pressure during sodium deficiency.
    McCaa RE
    Circ Res; 1977 May; 40(5 Suppl 1):I157-62. PubMed ID: 870226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldosterone suppression with dopamine infusion in low-renin hypertension.
    Holland OB; Thomas C; Brown H; Schindewolf D; Hillier Y; Gomez-Sanchez C
    J Clin Invest; 1983 Sep; 72(3):754-66. PubMed ID: 6309909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of upright posture on the aldosterone responses to dopamine, metoclopramide, angiotensin II, and adrenocorticotropin.
    Malchoff CD; Hughes JM; Carey RM
    J Clin Endocrinol Metab; 1987 Jul; 65(1):203-7. PubMed ID: 3034955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of metoclopramide on adrenal secretion in sheep: influence of dexamethasone and sodium intake.
    Cameron V; Espiner EA; Nicholls MG; Parratt S
    J Steroid Biochem; 1987 Jun; 26(6):717-21. PubMed ID: 3613572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.